BRINTELLIX 5 MG Izrael - angličtina - Ministry of Health

brintellix 5 mg

lundbeck israel ltd. - vortioxetine as hydrobromide - film coated tablets - vortioxetine as hydrobromide 5 mg - vortioxetine - brintellix is indicated for the treatment of major depressive episodes in adults.

BRINTELLIX 5 MG Izrael - angličtina - Ministry of Health

brintellix 5 mg

lundbeck israel ltd. - vortioxetine as hydrobromide - film coated tablets - vortioxetine as hydrobromide 5 mg - vortioxetine - brintellix is indicated for the treatment of major depressive episodes in adults.

SELINCRO 18 MG Izrael - angličtina - Ministry of Health

selincro 18 mg

lundbeck israel ltd. - nalmefene as hydrochloride dihydrate - film coated tablets - nalmefene as hydrochloride dihydrate 18.06 mg - nalmefene - selincro is indicated for the reduction of alcohol consumption in adult patients with alcohol dependence who have a high drinking risk level (drl), without physical withdrawal symptoms and who do not require immediate detoxification.selincro should only be prescribed in conjunction with continuous psychosocial support focused on treatment adherence and reducing alcohol consumption.selincro should be initiated only in patients who continue to have a high drl two weeks after initial assessment.

SELINCRO 18 MG Izrael - angličtina - Ministry of Health

selincro 18 mg

lundbeck israel ltd. - nalmefene as hydrochloride dihydrate - film coated tablets - nalmefene as hydrochloride dihydrate 18.06 mg - nalmefene - selincro is indicated for the reduction of alcohol consumption in adult patients with alcohol dependence who have a high drinking risk level (drl), without physical withdrawal symptoms and who do not require immediate detoxification.selincro should only be prescribed in conjunction with continuous psychosocial support focused on treatment adherence and reducing alcohol consumption.selincro should be initiated only in patients who continue to have a high drl two weeks after initial assessment.

CIPRALEX 10 MG Izrael - angličtina - Ministry of Health

cipralex 10 mg

lundbeck israel ltd. - escitalopram as oxalate - film coated tablets - escitalopram as oxalate 10 mg - escitalopram - treatment of depression and panic disorder. treatment of generalized anxiety disorder (gad) treatment of social anxiety disorder (social phobia). treatment of obsessive - compulsive disorder.

REXULTI  0.5 MG Izrael - angličtina - Ministry of Health

rexulti 0.5 mg

lundbeck israel ltd. - brexpiprazole - film coated tablets - brexpiprazole 0.5 mg - brexpiprazole - rexulti is indicated for:- as adjunctive therapy to antidepressants for the treatment of major depressive disorder (mdd) in adults- for treatment of schizophrenia in adults and pediatric patients ages 13 years and older.

REXULTI  1 MG Izrael - angličtina - Ministry of Health

rexulti 1 mg

lundbeck israel ltd. - brexpiprazole - film coated tablets - brexpiprazole 1 mg - brexpiprazole - rexulti is indicated for:- as adjunctive therapy to antidepressants for the treatment of major depressive disorder (mdd) in adults- for treatment of schizophrenia in adults and pediatric patients ages 13 years and older.

REXULTI  2 MG Izrael - angličtina - Ministry of Health

rexulti 2 mg

lundbeck israel ltd. - brexpiprazole - film coated tablets - brexpiprazole 2 mg - brexpiprazole - rexulti is indicated for:- as adjunctive therapy to antidepressants for the treatment of major depressive disorder (mdd) in adults- for treatment of schizophrenia in adults and pediatric patients ages 13 years and older.

REXULTI  3 MG Izrael - angličtina - Ministry of Health

rexulti 3 mg

lundbeck israel ltd. - brexpiprazole - film coated tablets - brexpiprazole 3 mg - brexpiprazole - rexulti is indicated for:- as adjunctive therapy to antidepressants for the treatment of major depressive disorder (mdd) in adults- for treatment of schizophrenia in adults and pediatric patients ages 13 years and older.

REXULTI  4 MG Izrael - angličtina - Ministry of Health

rexulti 4 mg

lundbeck israel ltd. - brexpiprazole - film coated tablets - brexpiprazole 4 mg - brexpiprazole - rexulti is indicated for:- as adjunctive therapy to antidepressants for the treatment of major depressive disorder (mdd) in adults- for treatment of schizophrenia in adults and pediatric patients ages 13 years and older.